HomeINDP • NASDAQ
add
Indaptus Therapeutics Inc
Previous close
$0.94
Day range
$0.89 - $0.96
Year range
$0.81 - $3.10
Market cap
11.41M USD
Avg Volume
24.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
WSJ
1 hour ago
Stock Market Today: Nasdaq, S&P 500 Fall; Nvidia, Macy's Stocks in Focus —
Live Updates
8.10%
2.76%
0.044%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.14M | -26.04% |
Net income | -3.07M | 21.76% |
Net profit margin | — | — |
Earnings per share | -0.32 | 31.91% |
EBITDA | -3.14M | 26.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.38M | -53.77% |
Total assets | 8.24M | -53.69% |
Total liabilities | 2.24M | -9.10% |
Total equity | 6.00M | — |
Shares outstanding | 10.20M | — |
Price to book | 1.59 | — |
Return on assets | -96.02% | — |
Return on capital | -126.61% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.07M | 21.76% |
Cash from operations | -2.51M | 32.71% |
Cash from investing | — | — |
Cash from financing | 2.59M | — |
Net change in cash | 78.94K | -97.58% |
Free cash flow | -1.28M | 45.09% |
About
Founded
2021
Website
Employees
7
